Author: Translucent Team

Support for Endometriosis Advocacy: A Statement from TransLucent Following recent press coverage, we wish to reaffirm our full support for our CEO, Steph Richards, as she champions increased funding and research for endometriosis. Steph’s mission in Parliament is as straightforward as it is vital: ensuring policymakers finally prioritise a condition that has been chronically underfunded and overlooked. Endometriosis can upend lives, causing debilitating pain, delayed diagnoses, and significant challenges both at work and at home. Real progress only occurs when the issue remains at the forefront of the political agenda—an area where Steph’s advocacy excels. For years, Steph has worked…

Robin Moira White explains how straightforward amendments to the Equality Act and Gender Recognition Act could resolve the legal mess created by the Supreme Court. Continue Reading Clearing up the Supreme Court’s Mess

Over 93000 women have signed the Not In Our Name declaration to reject transphobia and support trans inclusion in the UK. Continue Reading Over 93000 Women Are Supporting Trans Inclusion

Our letter sent today to  Rt Hon Wes Streeting MP Dear Minister for Health and Social Care, We write to express our grave concern that individuals who hold gender‑critical views are being permitted to participate in decisions directly affecting trans healthcare, including within regulatory and clinical settings, and that trans people themselves are often excluded from the same processes. The fact that Professor George has been recused from the MHRA puberty blocker panel is a clear recognition that certain framings of sex and gender can distort clinical decision‑making. However, the issue extends far beyond one individual, reaching into the…

The Tip of the Iceberg: Facing the Truth About Trans Youth Suicide Content Warning: Suicide.  Behind every statistic is a young person whose life was cut short, a family left grieving, and a future lost due to a society unwilling to acknowledge the truth. For years, the trans community has raised concerns about the mental health and well-being of our youth. We have witnessed their struggles, supported families in crisis, and, tragically, mourned losses. Despite this, our calls for action have often been met with scepticism. Decision-makers have dismissed our concerns as anecdotal or minimised the scale of the issue;…

A monumental 86 percent of respondents voted to maintain trans-inclusive access at the historic Hampstead heath bathing ponds. Continue Reading Hampstead Heath Ponds

The 5,000-Year Legacy: Gender Fluidity in the Cradle of Civilisation At TransLucent, we often hear that gender fluidity is just a “modern trend” or something invented by the West. However, when we look more closely at history, it becomes clear that gender diversity is not new—it has existed for millennia and was even regarded as sacred in many cultures. In Ancient Mesopotamia—the so-called “Cradle of Civilisation”—gender diversity was at the heart of their worldview. At the centre was Inanna (Sumerian) or Ishtar (Akkadian), the Queen of Heaven, whose power came from her ability to break down boundaries. The Lady of…

WI Support Group: Group aims and objectives: This TransLucent subgroup has been established for all members of the Women’s Institute to gather, discuss, exchange information, and provide mutual support.  Membership of this group is not restricted to WI members; it is open to past WI members, trans allies, allies, and supporters of an inclusive WI. This follows the December 3rd 2025 announcement by the Women’s Institute of England and Wales that trans women will no longer be accepted as members, and that existing members will not be able to renew their membership. Founder of this group: Petra Wenham, a member…

Evidence from 382 FOI requests shows that the alleged crisis of trans women in single-sex spaces is unsupported by actual recorded complaints. Continue Reading What FOI Data Shows About Trans Women in Single Sex Spaces

TransLucent stands by its critique of the Cass Review as international evidence and clinical guidelines validate concerns over its methodology. Continue Reading Standing Firm: Why Our August 2024 Response to the Cass Review Remains Our Position